BRK.B vs IONS · rev $371.44B vs rev $514.0M
BRK.B (BRK.B) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
BRK.B currently screens at market cap $0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the BRK.B and IONS stock pages for the full models.
Not investment advice.